Tizanidine Tablet
Product Images NDC 63187-673

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63187-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-673-90 (Tizanidine 4mg)

Label for Tizanidine 4 mg oral tablets by Proficient Rx LP. The label indicates 30 tablets per container with each tablet containing 4.576 mg tizanidine HCl USP, equivalent to 4 mg tizanidine base. It includes product ID PT067330 and manufacturer Alkaloida Chemical Company Zrt., Hungary. The label has warnings emphasizing that Tizanidine tablets are not interchangeable with capsules.*

FDA Label Image

Tizanidine-figure1 (Tizanidine Figure1)

A pharmacokinetic curve showing plasma concentration of Tizanidine (ng/mL) over time (hours) after dosing. The graph compares plasma levels of 4 mg Tizanidine tablets and capsules, both with and without food intake, over a 24-hour period. The chart shows time-concentration profiles for four conditions: tablets with food, tablets without food, capsules with food, and capsules without food.*

FDA Label Image

Tizanidine-figure2 (Tizanidine Figure2)

A line graph showing improvement in Ashworth Score over 6 hours post-dose, comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph indicates improvement peaking around 2 hours for tizanidine doses, then declining towards 6 hours, with error bars for variability.*

FDA Label Image

Tizanidine-figure3 (Tizanidine Figure3)

A line plot showing the improvement in Ashworth Score over time for two groups: tizanidine (mean dose 28.8 mg) and placebo. The x-axis marks three study points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). The y-axis shows improvement scores ranging from -6 to 2, with tizanidine consistently showing greater improvement (negative score) compared to placebo.*

FDA Label Image

Tizanidine-structure (Tizanidine Structure)

Chemical structure of tizanidine hydrochloride, showing the arrangement of chlorine, nitrogen, sulfur, and hydrogen atoms in the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.